UBS Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.7M | Buy |
562,040
+3,389
| +0.6% | +$75.3K | ﹤0.01% | 3092 |
|
|
2025
Q4 | $14.5M | Sell |
558,651
-296,210
| -35% | -$7.04M | ﹤0.01% | 2914 |
|
|
2025
Q3 | $22M | Sell |
854,861
-174,028
| -17% | -$4.27M | ﹤0.01% | 2454 |
|
|
2025
Q2 | $24.6M | Buy |
1,028,889
+607,057
| +144% | +$15.3M | 0.01% | 2163 |
|
|
2025
Q1 | $10.5M | Sell |
421,832
-952,957
| -69% | -$22.8M | ﹤0.01% | 2986 |
|
|
2024
Q4 | $25.9M | Buy |
1,374,789
+1,184,034
| +621% | +$20.8M | 0.01% | 2059 |
|
|
2024
Q3 | $2.87M | Buy |
190,755
+125,097
| +191% | +$2.14M | ﹤0.01% | 3642 |
|
|
2024
Q2 | $1.88M | Sell |
65,658
-99,803
| -60% | -$2.84M | ﹤0.01% | 3833 |
|
|
2024
Q1 | $4.83M | Buy |
165,461
+39,875
| +32% | +$1.22M | ﹤0.01% | 3009 |
|
|
2023
Q4 | $4.24M | Buy |
125,586
+69,513
| +124% | +$2.03M | ﹤0.01% | 2964 |
|
|
2023
Q3 | $1.72M | Buy |
56,073
+31,699
| +130% | +$1.14M | ﹤0.01% | 3588 |
|
|
2023
Q2 | $977K | Sell |
24,374
-5,177
| -18% | -$214K | ﹤0.01% | 4275 |
|
|
2023
Q1 | $1.21M | Buy |
29,551
+2,145
| +8% | +$85.3K | ﹤0.01% | 3941 |
|
|
2022
Q4 | $1.06M | Buy |
27,406
+6,763
| +33% | +$329K | ﹤0.01% | 4022 |
|
|
2022
Q3 | $1.1M | Sell |
20,643
-1,642
| -7% | -$91.3K | ﹤0.01% | 3674 |
|
|
2022
Q2 | $1.3M | Buy |
22,285
+764
| +4% | +$50K | ﹤0.01% | 3502 |
|
|
2022
Q1 | $1.64M | Sell |
21,521
-2,027
| -9% | -$135K | ﹤0.01% | 3629 |
|
|
2021
Q4 | $1.42M | Sell |
23,548
-1,533
| -6% | -$84.5K | ﹤0.01% | 4071 |
|
|
2021
Q3 | $1.41M | Sell |
25,081
-10,422
| -29% | -$601K | ﹤0.01% | 3890 |
|
|
2021
Q2 | $2.15M | Sell |
35,503
-12,500
| -26% | -$791K | ﹤0.01% | 3506 |
|
|
2021
Q1 | $3.37M | Sell |
48,003
-13,283
| -22% | -$949K | ﹤0.01% | 3014 |
|
|
2020
Q4 | $3.67M | Buy |
61,286
+36,384
| +146% | +$2.13M | ﹤0.01% | 2774 |
|
|
2020
Q3 | $1.5M | Sell |
24,902
-13,516
| -35% | -$785K | ﹤0.01% | 3329 |
|
|
2020
Q2 | $2.02M | Sell |
38,418
-8,765
| -19% | -$366K | ﹤0.01% | 2875 |
|
|
2020
Q1 | $1.58M | Sell |
47,183
-27,529
| -37% | -$1.14M | ﹤0.01% | 2978 |
|
|
2019
Q4 | $3.38M | Buy |
74,712
+56,874
| +319% | +$2.42M | ﹤0.01% | 2997 |
|
|
2019
Q3 | $679K | Sell |
17,838
-900
| -5% | -$35.9K | ﹤0.01% | 4295 |
|
|
2019
Q2 | $815K | Buy |
18,738
+2,250
| +14% | +$95.5K | ﹤0.01% | 3911 |
|
|
2019
Q1 | $628K | Buy |
16,488
+9,264
| +128% | +$362K | ﹤0.01% | 3907 |
|
|
2018
Q4 | $311K | Sell |
7,224
-1,149
| -14% | -$53.6K | ﹤0.01% | 4604 |
|
|
2018
Q3 | $411K | Buy |
8,373
+621
| +8% | +$26.8K | ﹤0.01% | 4551 |
|
|
2018
Q2 | $248K | Sell |
7,752
-17,384
| -69% | -$600K | ﹤0.01% | 4798 |
|
|
2018
Q1 | $783K | Sell |
25,136
-1,100
| -4% | -$39.2K | ﹤0.01% | 3904 |
|
|
2017
Q4 | $1.2M | Buy |
26,236
+2,310
| +10% | +$91.6K | ﹤0.01% | 3628 |
|
|
2017
Q3 | $899K | Buy |
23,926
+6,117
| +34% | +$246K | ﹤0.01% | 3792 |
|
|
2017
Q2 | $849K | Buy |
17,809
+3,336
| +23% | +$155K | ﹤0.01% | 3757 |
|
|
2017
Q1 | $660K | Buy |
14,473
+7,117
| +97% | +$308K | ﹤0.01% | 3850 |
|
|
2016
Q4 | $238K | Buy |
7,356
+2,392
| +48% | +$79.8K | ﹤0.01% | 4671 |
|
|
2016
Q3 | $170K | Sell |
4,964
-408
| -8% | -$16K | ﹤0.01% | 4658 |
|
|
2016
Q2 | $181K | Sell |
5,372
-416
| -7% | -$20.4K | ﹤0.01% | 4609 |
|
|
2016
Q1 | $307K | Sell |
5,788
-501
| -8% | -$29.3K | ﹤0.01% | 4168 |
|
|
2015
Q4 | $483K | Buy |
6,289
+349
| +6% | +$19.8K | ﹤0.01% | 3976 |
|
|
2015
Q3 | $244K | Buy |
5,940
+5,096
| +604% | +$312K | ﹤0.01% | 4471 |
|
|
2015
Q2 | $59K | Sell |
844
-12,353
| -94% | -$973K | ﹤0.01% | 5854 |
|
|
2015
Q1 | $1.17M | Sell |
13,197
-5,970
| -31% | -$606K | ﹤0.01% | 3443 |
|
|
2014
Q4 | $1.7M | Buy |
+19,167
| New | +$1.81M | ﹤0.01% | 3060 |
|
Other funds holding PCRX
DPCM
VPM
VCM
